Dunbar Ivy
Overview
Explore the profile of Dunbar Ivy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ivy D, Rosenzweig E, Abman S, Beghetti M, Bonnet D, Douwes J, et al.
Eur Respir J
. 2025 Jan;
65(1).
PMID: 39746763
No abstract available.
2.
Winters R, Forbes L, Ivy D, Cool C, Park B, Hountras P, et al.
Respirol Case Rep
. 2024 Nov;
12(11):e70064.
PMID: 39588328
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary vascular disease that is difficult to distinguish clinically from pulmonary arterial hypertension (PAH). Multiple genes have been implicated in disease...
3.
Ivy D, Rosenzweig E, Abman S, Beghetti M, Bonnet D, Douwes J, et al.
Eur Respir J
. 2024 Aug;
64(4).
PMID: 39209483
Paediatric pulmonary arterial hypertension (PAH) shares common features with adult disease, but is associated with several additional disorders and challenges that require unique approaches. This article discusses recent advances, ongoing...
4.
Wacker J, Humpl T, Berger R, Ivy D, Bowers D, Bonnet D, et al.
Front Cardiovasc Med
. 2024 Feb;
11:1344014.
PMID: 38370158
Aims: A proportion of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) do not fit in the current classification. We aimed to analyse the applicability of an...
5.
Ivy D, Beghetti M, Juaneda-Simian E, Ravindranath R, Lukas M, Machlitt-Northen S, et al.
Eur J Pediatr
. 2024 Feb;
183(5):2141-2153.
PMID: 38366267
This open-label, extension study assessed long-term safety, tolerability, and efficacy of ambrisentan in a pediatric population (age 8- < 18 years) with pulmonary arterial hypertension (PAH). Following completion of a...
6.
Ivy D, Beghetti M, Juaneda-Simian E, Miller D, Lukas M, Ioannou C, et al.
J Pediatr X
. 2023 Jun;
5:100055.
PMID: 37332660
Objective: To assess the safety and efficacy of the endothelin receptor antagonist ambrisentan in pediatric pulmonary arterial hypertension (PAH). Study Design: In this open-label, phase IIb study, patients with PAH...
7.
Beghetti M, Ivy D, Scott N, Machlitt-Northen S, Lukas M
Eur J Pediatr
. 2023 Feb;
182(5):2453-2454.
PMID: 36847876
No abstract available.
8.
Shorofsky M, Morgan G, Mejia E, Rodriguez S, Greene M, Sheaks P, et al.
Pediatr Cardiol
. 2023 Feb;
44(5):1125-1134.
PMID: 36723625
Background: Pulmonary vein stenosis (PVS) is a growing problem for the pediatric congenital heart population. Sirolimus has previously been shown to improve survival and slow down the progression of in-stent...
9.
Ucros S, Aparicio C, Castro-Rodriguez J, Ivy D
Pediatr Pulmonol
. 2022 Dec;
58(4):1059-1067.
PMID: 36562650
Introduction: High altitude pulmonary edema (HAPE) is a form of acute noncardiogenic pulmonary edema caused by altitude-related hypoxia seen in children as well as in adults. In this systematic review...
10.
Yang J, Ambade A, Nies M, Griffiths M, Damico R, Vaidya D, et al.
Pulm Circ
. 2022 May;
12(1):e12007.
PMID: 35506100
Hepatoma-derived growth factor (HDGF) was previously shown to be associated with increased mortality in a small study of idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH). In this study,...